Autoimmune Disease Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently released a comprehensive report on the global Autoimmune Disease Testing Market, offering an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report provides valuable insights into the market landscape, aiding stakeholders in making informed decisions.

Key Insights:

Autoimmune Disease Testing Market Size (2024E): US$ 6 Bn
Projected Market Value (2031F): US$ 12.6 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 9.2%

Autoimmune Disease Testing Market - Report Scope:

The Autoimmune Disease Testing market refers to the diagnostic services and tests used to detect autoimmune diseases, including conditions such as rheumatoid arthritis, lupus, and multiple sclerosis. These tests are essential in the early detection and management of autoimmune disorders, offering personalized treatment options for patients. The market is driven by the rising prevalence of autoimmune diseases, growing awareness about early diagnosis, and technological advancements in diagnostic testing methods. These tests are used in both clinical and homecare settings, with a focus on providing accurate and timely diagnosis.

Market Growth Drivers:

Several factors are contributing to the growth of the global Autoimmune Disease Testing market, including the increasing prevalence of autoimmune diseases, advancements in diagnostic technologies, and a growing demand for personalized medicine. Additionally, the rise in healthcare expenditure, along with improvements in healthcare infrastructure, is boosting the demand for accurate and efficient testing methods. The adoption of advanced diagnostic tools, such as molecular diagnostics and biomarker-based tests, is further accelerating market growth. Increasing awareness about autoimmune diseases and the availability of specialized tests are also factors supporting the market's expansion.

Market Restraints:

Despite its growth potential, the Autoimmune Disease Testing market faces challenges, including the high cost of advanced diagnostic tests and the lack of standardization in testing procedures. The complexity of autoimmune diseases, which often overlap with other conditions, can make diagnosis difficult, leading to challenges in test accuracy and interpretation. Furthermore, limited access to advanced diagnostic tools in developing regions, coupled with the high costs of such tests, may inhibit market growth. Additionally, regulatory hurdles and the need for continuous innovation in testing methodologies pose challenges to industry players.

Market Opportunities:

The Autoimmune Disease Testing market presents significant opportunities, driven by the demand for early-stage diagnosis, advancements in biomarker research, and the development of more affordable testing solutions. The rising focus on precision medicine and the increasing number of healthcare providers offering specialized testing services create opportunities for market players. Expansion into emerging markets, where awareness about autoimmune diseases is growing, presents new avenues for growth. Moreover, strategic partnerships with healthcare providers and insurance companies could help make testing services more accessible and affordable, thereby expanding the customer base.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the global Autoimmune Disease Testing market?
Which diagnostic methods and test types are leading the market in terms of demand and revenue?
How are technological advancements, such as molecular diagnostics, influencing the autoimmune disease testing industry?
Who are the leading players in the Autoimmune Disease Testing market, and what strategies are they employing to maintain their market positions?
What are the emerging trends and future prospects in the global Autoimmune Disease Testing market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Autoimmune Disease Testing market, such as Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific, are focusing on expanding their diagnostic test portfolios, improving testing accuracy, and enhancing the speed of results. These companies are investing in research and development to introduce new, more efficient diagnostic tools while also expanding their geographic reach through collaborations with healthcare institutions. Partnerships with insurance companies and healthcare providers are crucial for enhancing service accessibility and ensuring long-term market growth. Furthermore, a focus on regulatory compliance, product innovation, and service quality is key to maintaining a competitive edge in the industry.

Key Companies Profiled:

Abbott Laboratories
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd
Siemens Healthineers
Bio-Rad Laboratories
Beckman Coulter (Danaher Corporation)
Quest Diagnostics
PerkinElmer, Inc.
Hologic, Inc.
Grifols
bioMerieux
Werfen (Inova Diagnostics)
Ortho Clinical Diagnostics
Trinity Biotech
EUROIMMUN (A PerkinElmer Company)

Autoimmune Disease Testing Industry Segmentation

By Product Type

Instruments
Reagents and Consumables

By Disease Type

Systemic Lupus Erythematosus
Scleroderma
Vasculitis
Inflammatory Bowel Disease
Rheumatoid Arthritis

By Test Type

Inflammatory Markers
Routine Laboratory Tests
Anti-Thyroglobulin Antibody
Antibodies and Immunology Test

By End User

Hospitals and Clinics
Diagnostic Laboratories
Research Laboratories

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
The Middle East and Africa

Product Code: PMRREP34958

1. Executive Summary

1.1. Global Autoimmune Disease Testing Market Snapshot, 2024 - 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Product Adoption Analysis
3.2. Technology Assessment
3.3. Regulatory Landscape
3.4. Value Chain Analysis
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter's Five Force Analysis

4. Global Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
- 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
4.3. Global Autoimmune Disease Testing Market Outlook: Product Type
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2023
- 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
  - 4.3.3.1. Instruments
  - 4.3.3.2. Reagents & Consumables
4.4. Market Attractiveness Analysis: Product Type
4.5. Global Autoimmune Disease Testing Market Outlook: Disease Type
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Disease Type, 2019 - 2023
- 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
  - 4.5.3.1. Systemic Lupus Erythematosus
  - 4.5.3.2. Scleroderma
  - 4.5.3.3. Vasculitis
  - 4.5.3.4. Inflammatory Bowel Disease
  - 4.5.3.5. Rheumatoid Arthritis
  - 4.5.3.6. Others
4.6. Market Attractiveness Analysis: Disease Type
4.7. Global Autoimmune Disease Testing Market Outlook: Test Type
- 4.7.1. Introduction / Key Findings
- 4.7.2. Historical Market Size (US$ Bn) Analysis, By Test Type, 2019 - 2023
- 4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
  - 4.7.3.1. Inflammatory Markers
  - 4.7.3.2. Routine Laboratory Tests
  - 4.7.3.3. Anti-Thyroglobulin Antibody
  - 4.7.3.4. Antibodies and Immunology Test
  - 4.7.3.5. Others
4.8. Market Attractiveness Analysis: Test Type
4.9. Global Autoimmune Disease Testing Market Outlook: End User
- 4.9.1. Introduction / Key Findings
- 4.9.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
- 4.9.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  - 4.9.3.1. Hospitals & Clinics
  - 4.9.3.2. Diagnostic Laboratories
  - 4.9.3.3. Research Laboratories
  - 4.9.3.4. Others
4.10. Market Attractiveness Analysis: End User

5. Global Autoimmune Disease Testing Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Autoimmune Disease Testing Market Outlook: Historical (2019 - 2024) and Forecast (2024 - 2031)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 6.3.1. By Country
- 6.3.2. By Product Type
- 6.3.3. By Disease Type
- 6.3.4. By Test Type
- 6.3.5. By End User
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
- 6.4.1. U.S.
- 6.4.2. Canada
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
- 6.5.1. Instruments
- 6.5.2. Reagents & Consumables
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
- 6.6.1. Systemic Lupus Erythematosus
- 6.6.2. Scleroderma
- 6.6.3. Vasculitis
- 6.6.4. Inflammatory Bowel Disease
- 6.6.5. Rheumatoid Arthritis
- 6.6.6. Others
6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
- 6.7.1. Inflammatory Markers
- 6.7.2. Routine Laboratory Tests
- 6.7.3. Anti-Thyroglobulin Antibody
- 6.7.4. Antibodies and Immunology Test
- 6.7.5. Others
6.8. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
- 6.8.1. Hospitals & Clinics
- 6.8.2. Diagnostic Laboratories
- 6.8.3. Research Laboratories
- 6.8.4. Others
6.9. Market Attractiveness Analysis

7. Europe Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 7.2.1. By Country
- 7.2.2. By Product Type
- 7.2.3. By Disease Type
- 7.2.4. By Test Type
- 7.2.5. By End User
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
- 7.4.1. Instruments
- 7.4.2. Reagents & Consumables
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
- 7.5.1. Systemic Lupus Erythematosus
- 7.5.2. Scleroderma
- 7.5.3. Vasculitis
- 7.5.4. Inflammatory Bowel Disease
- 7.5.5. Rheumatoid Arthritis
- 7.5.6. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
- 7.6.1. Inflammatory Markers
- 7.6.2. Routine Laboratory Tests
- 7.6.3. Anti-Thyroglobulin Antibody
- 7.6.4. Antibodies and Immunology Test
- 7.6.5. Others
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
- 7.7.1. Hospitals & Clinics
- 7.7.2. Diagnostic Laboratories
- 7.7.3. Research Laboratories
- 7.7.4. Others
7.8. Market Attractiveness Analysis

8. East Asia Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 8.2.1. By Country
- 8.2.2. By Product Type
- 8.2.3. By Disease Type
- 8.2.4. By Test Type
- 8.2.5. By End User
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
- 8.4.1. Instruments
- 8.4.2. Reagents & Consumables
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
- 8.5.1. Systemic Lupus Erythematosus
- 8.5.2. Scleroderma
- 8.5.3. Vasculitis
- 8.5.4. Inflammatory Bowel Disease
- 8.5.5. Rheumatoid Arthritis
- 8.5.6. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
- 8.6.1. Inflammatory Markers
- 8.6.2. Routine Laboratory Tests
- 8.6.3. Anti-Thyroglobulin Antibody
- 8.6.4. Antibodies and Immunology Test
- 8.6.5. Others
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
- 8.7.1. Hospitals & Clinics
- 8.7.2. Diagnostic Laboratories
- 8.7.3. Research Laboratories
- 8.7.4. Others
8.8. Market Attractiveness Analysis

9. South Asia & Oceania Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 9.2.1. By Country
- 9.2.2. By Product Type
- 9.2.3. By Disease Type
- 9.2.4. By Test Type
- 9.2.5. By End User
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
- 9.4.1. Instruments
- 9.4.2. Reagents & Consumables
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
- 9.5.1. Systemic Lupus Erythematosus
- 9.5.2. Scleroderma
- 9.5.3. Vasculitis
- 9.5.4. Inflammatory Bowel Disease
- 9.5.5. Rheumatoid Arthritis
- 9.5.6. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
- 9.6.1. Inflammatory Markers
- 9.6.2. Routine Laboratory Tests
- 9.6.3. Anti-Thyroglobulin Antibody
- 9.6.4. Antibodies and Immunology Test
- 9.6.5. Others
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
- 9.7.1. Hospitals & Clinics
- 9.7.2. Diagnostic Laboratories
- 9.7.3. Research Laboratories
- 9.7.4. Others
9.8. Market Attractiveness Analysis

10. Latin America Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 10.2.1. By Country
- 10.2.2. By Product Type
- 10.2.3. By Disease Type
- 10.2.4. By Test Type
- 10.2.5. By End User
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
- 10.4.1. Instruments
- 10.4.2. Reagents & Consumables
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
- 10.5.1. Systemic Lupus Erythematosus
- 10.5.2. Scleroderma
- 10.5.3. Vasculitis
- 10.5.4. Inflammatory Bowel Disease
- 10.5.5. Rheumatoid Arthritis
- 10.5.6. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
- 10.6.1. Inflammatory Markers
- 10.6.2. Routine Laboratory Tests
- 10.6.3. Anti-Thyroglobulin Antibody
- 10.6.4. Antibodies and Immunology Test
- 10.6.5. Others
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
- 10.7.1. Hospitals & Clinics
- 10.7.2. Diagnostic Laboratories
- 10.7.3. Research Laboratories
- 10.7.4. Others
10.8. Market Attractiveness Analysis

11. Middle East & Africa Autoimmune Disease Testing Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 11.2.1. By Country
- 11.2.2. By Product Type
- 11.2.3. By Disease Type
- 11.2.4. By Test Type
- 11.2.5. By End User
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
- 11.4.1. Instruments
- 11.4.2. Reagents & Consumables
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2024 - 2031
- 11.5.1. Systemic Lupus Erythematosus
- 11.5.2. Scleroderma
- 11.5.3. Vasculitis
- 11.5.4. Inflammatory Bowel Disease
- 11.5.5. Rheumatoid Arthritis
- 11.5.6. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2024 - 2031
- 11.6.1. Inflammatory Markers
- 11.6.2. Routine Laboratory Tests
- 11.6.3. Anti-Thyroglobulin Antibody
- 11.6.4. Antibodies and Immunology Test
- 11.6.5. Others
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
- 11.7.1. Hospitals & Clinics
- 11.7.2. Diagnostic Laboratories
- 11.7.3. Research Laboratories
- 11.7.4. Others
11.8. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2024
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Abbott Laboratories
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Thermo Fisher Scientific
- 12.3.3. F. Hoffmann-La Roche Ltd
- 12.3.4. Siemens Healthineers
- 12.3.5. Bio-Rad Laboratories
- 12.3.6. Beckman Coulter (Danaher Corporation)
- 12.3.7. Quest Diagnostics
- 12.3.8. PerkinElmer, Inc.
- 12.3.9. Hologic, Inc.
- 12.3.10. Grifols
- 12.3.11. bioMerieux
- 12.3.12. Werfen (Inova Diagnostics)
- 12.3.13. Ortho Clinical Diagnostics
- 12.3.14. Trinity Biotech
- 12.3.15. EUROIMMUN (A PerkinElmer Company)

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations